FLORENCE, ITALY, May 22, 2023, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated molecular diagnostics platform for the processing of various testing portfolios through real-time PCR.

Rome, 21-25 May 2023

Rome, 20 - 21 May 2023

FLORENCE, ITALY, April 19ᵗʰ 2023, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others), building on several years of fruitful collaboration  with Boditech Med Inc. (Boditech)  in Italy.